Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure

Human Reproduction

Volumn 23, Issue 6, 2008, Pages 1457-1465

  Kang, HyunJun ^a   Lee, Seung Ku ^a   Kim, Min Ho ^a   Song, JiHyun ^a   Bae, Su Jin ^a   Kim, Nam Keun ^a   Lee, Sook Hwan ^b   Kwack, KyuBum ^a  

^a CHA University   (South Korea)

^b Ministry of Health and Welfare   (South Korea)

Author keywords

Haplotype; LD mapping; POF; PTHB1 gene; SNP

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; BIOASSAY; CHROMOSOME 7P; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HAPLOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; PARATHYROID HORMONE RESPONSIVE B1 GENE; PATHOGENESIS; PREMATURE OVARIAN FAILURE; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 44449155898     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den086     Document Type: Article

References (49)

1. Adams AE, Rosenblatt M, Suva LJ. Identification of a novel parathyroid hormone-responsive gene in human osteoblastic cells. Bone 1999;24:305-313.
2. Aittomaki K, Lucena JL, Pakarinen P, Perheentupa J. Mutation in the follicle-stimulating hormone receptor gene cause hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-968.
3. Ammann F. Investigations cliniques et genetiques sur le syndrome de Bardet-Biedl en Suisse. J Genet Hum 1970;18:1-310.
4. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
5. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 1999;36:437-446.
6. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003;348:1170-1175.
7. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 2005;437:1365-1369.
8. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997;278:1580-1581.
9. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999;51:97-99.
10. Coulam CB. Premature gonadal failure. Fertil Steril 1982;38:645-655.
11. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
12. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311-322.
13. Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993;48:15- 23.
14. Forti E, Aksanov O, Birk RZ. Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis. Int J Biochem Cell Biol 2007;39:1055-1062.
15. Frisch RE. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynaecol 1990;4:419-439.
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
17. Gougeon A. Inhibin, activin, follistatin, and transforming growth factor beta (TGFbeta): presence in the ovary and possible role in the regulation of folliculogenesis in primates. Contracept Fertil Sex 1994;22:571- 576.
18. Green JS, Parfrey PS, Harnett JD, Farid NR, Cramer BC, Johnson G, Heath O, McManamon PJ, O'Leary E, Pryse-Phillips W. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989;321:1002-1009.
19. Grenman S, Ronnemaa T, Irjala K, Kaihola HL, Gronroos M. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J Clin Endocrinol Metab 1986;63:1257-1261.
20. Gunderson KL, Kruglyak S, Graige MS, Garcia F, Kermani BG, Zhao C, Che D, Dickinson T, Wickham E, Bierle J et al. Decoding randomly ordered DNA arrays. Genome Res 2004;14:870-877.
21. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 2005;37:549-554.
22. Harris SE, Chand AL, Winship IM, Gersak K, Nishi Y, Yanase T, Nawata H, Shelling AN. INHA promoter polymorphisms are associated with premature ovarian failure. Mol Hum Reprod 2005;11:779-784.
23. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
24. Hviid TV, Hylenius S, Rørbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003;55:63-79.
25. Jeong HJ, Cho SW, Kim HA, Lee SH, Cho JG, Choi DH, Kwon H, Cha WT, Han JE, Cha KY. G769A variation of inhibin alpha-gene in korean women with premature ovarian failure. Yonsei Med J 2004;45:479-482.
26. Jones R, Pembrey M, Golding J, Herrick D. The search for genenotype/phenotype associations and the phenome scan. Paediatr Perinat Epidemiol 2005;19:264-275.
27. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999;22:139-144.
28. Laml T, Schulz-Lobmeyr I, Obruca A, Huber JC, Hartmann BW. Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000;14:292-302.
29. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormonereceptor gene. N Engl J Med 1996;334:507-512.
30. Layman LC, Shelley ME, Huey LO, Wall SW, Tho SP, McDonough PG. Follicle-stimulating hormone beta gene structure in premature ovarian failure. Fertil Steril 1993;60:852-857.
31. Marchand L, Polychronakos C. Evaluation of polymorphic splicing in the mechanism of the association of the insulin gene with diabetes. Diabetes 2007;56:709-713.
32. Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VK. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet 1993;5:83-86.
33. Nishimura DY, Swiderski RE, Searby CC, Berg EM, Ferguson AL, Hennekam R, Merin S, Weleber RG, Biesecker LG, Stone EM et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am J Hum Genet 2005;77:1021-1033.
34. Ohashi J, Clark AG. Application of the stepwise focusing method to optimize the cost-effectiveness of genome-wide association studies with limited research budgets for genotyping and phenotyping. Ann Hum Genet 2005;69:323-328.
35. Pal L, Santoro N. Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002;1:413-423.
36. Phimister EG. Medicine and the racial divide. N Engl J Med 2003;348:1081-1082.
37. Richards JS. Perspective: the ovarian follicle - a perspective in 2001. Endocrinology 2001;142:2184-2193.
38. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002;57:195-220.
39. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-1517.
40. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-856.
41. Santoro N. Research on the mechanisms of premature ovarian failure. J Soc Gynecol Investig 2001;8:S10-S12.
42. Santoro N, Lasley B, McConnell D, Allsworth J, Crawford S, Gold EB, Finkelstein JS, Greendale GA, Kelsey J, Korenman S et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab 2004;89:2622-2631.
43. Satagopan JM, Elston RC. Optimal two-stage genotyping in population-based association studies. Genet Epidemiol 2003;25:149-157.
44. Schachat AP, Maumenee IH. Bardet-Biedl syndrome and related disorders. Arch Ophthalmol 1982;100:285-288.
45. Sham PC. Statistics in human genetics. Stat Methods Med Res 1998;7:279-300.
46. Sherman BM, Korenman SG. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab 1974;39:145-149.
47. Slavotinek AM, Biesecker LG. Phenotypic overlap of McKusick-Kaufman syndrome with Bardet-Biedl syndrome: a literature review. Am J Med Genet 2000;95:208-215.
48. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978- 989.
49. Takahashi K, Ozaki T, Okada M, Kurioka H, Kanasaki H, Miyazaki K. Increased prevalence of luteinizing hormone beta-subunit variant in patients with premature ovarian failure. Fertil Steril 1999;71:96-101.